Cargando…

Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries

BACKGROUND: Specialized pro-resolving lipid mediators (SPM) such as resolvin D1 (RvD1) attenuate inflammation and exhibit vasculo-protective properties. METHODS: We investigated poly-lactic-co-glycolic acid (PLGA)-based nanoparticles (NP), containing a peptide targeted to tissue factor (TF) for deli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levy, Elizabeth S., Kim, Alexander S., Werlin, Evan, Chen, Mian, Sansbury, Brian E., Spite, Matthew, Desai, Tejal A., Conte, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692706/ https://www.ncbi.nlm.nih.gov/pubmed/38045567 http://dx.doi.org/10.1016/j.jvssci.2023.100126

Ejemplares similares

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
por: Basil, Maria C., et al.
Publicado: (2015)

Care of the injured worldwide: trauma still the neglected disease of modern society
por: Sakran, Joseph V, et al.
Publicado: (2012)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
por: Yin, Ping, et al.
Publicado: (2018)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
por: Rasquel-Oliveira, Fernanda S., et al.
Publicado: (2023)

17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury
por: Kim, Alexander S., et al.
Publicado: (2022)

Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms
por: Filiberto, Amanda C., et al.
Publicado: (2023)

Specialized Pro-Resolving Mediators and the Lymphatic System
por: Kraft, Jamie D., et al.
Publicado: (2021)

Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
por: Fosshaug, Linn E., et al.
Publicado: (2019)

Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation
por: Lee, Chun-Teh, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair
por: Tiberi, Marta, et al.
Publicado: (2021)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
por: Schebb, Nils Helge, et al.
Publicado: (2022)

Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren’s syndrome
por: dos Santos, Harim T., et al.
Publicado: (2023)

The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells
por: Chatterjee, Anuran, et al.
Publicado: (2014)

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
por: de Gaetano, Monica, et al.
Publicado: (2018)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation
por: Ferguson, Brittney, et al.
Publicado: (2020)

2204 Characterizing specialized pro-resolving lipid mediators and synthesis pathways in veterans with peripheral artery disease
por: Ramirez, Joel, et al.
Publicado: (2018)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
por: Kang, Gyeoung Jin, et al.
Publicado: (2020)

PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)
por: Regidor, Pedro-Antonio, et al.
Publicado: (2022)

Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
por: Kytikova, Oxana, et al.
Publicado: (2019)

Dynamic lipid mediator changes support macrophage subtype transitions during muscle regeneration
por: Giannakis, Nikolas, et al.
Publicado: (2019)

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
por: Ferreira, Inês, et al.
Publicado: (2022)

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
por: de Wit, Nienke M., et al.
Publicado: (2021)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
por: Sousa, Ana Beatriz, et al.
Publicado: (2023)

The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery
por: Schulte, Fabian, et al.
Publicado: (2020)

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
por: Yasmeen, Nusrath, et al.
Publicado: (2023)

Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
por: Irún, Pilar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rppt53anhiivci0495r3pdbh6